Double Umbilical Cord Blood Transplantation in High-Risk Hematological Patients: A Phase II Study Focusing on the Mechanism of Graft Predominance-Reference-Cited by-同舟云学术

Double Umbilical Cord Blood Transplantation in High-Risk Hematological Patients: A Phase II Study Focusing on the Mechanism of Graft Predominance

Published:2019-08-09 Issue:5 Volume:3 Page:
ISSN:2572-9241
Container-title:HemaSphere
language:en
Short-container-title:

Author:

Kalin Burak,ter Borg Mariëtte,Wijers Rebecca,Somers Judith A.E.,van der Holt Bronno,van Bergen Cornelis A.M.,Petersen Eefke J.,Kuball Jurgen,Meijer Ellen,Schaap Nicolaas P.M.,Zeerleder Sacha S.,Broers Annoek E.,Braakman Eric,Falkenburg J.H. Frederik,Lamers Cor H.J.,Cornelissen Jan J.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Hematology

Reference15 articles.

1. Hematopoietic stem-cell transplantation;Copelan;N Engl J Med,2006

2. HLA match likelihoods for hematopoietic stem-cell grafts in the U.S. registry;Gragert;N Engl J Med,2014

3. Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy;Barker;Blood,2005

4. Single-unit dominance after double-unit umbilical cord blood transplantation coincides with a specific CD8+ T-cell response against the nonengrafted unit;Gutman;Blood,2010

5. Rapid induction of single donor chimerism after double umbilical cord blood transplantation preceded by reduced intensity conditioning: results of the HOVON 106 phase II study;Somers;Haematologica,2014

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bioengineered 3D microfibrous‐matrix modulates osteopontin release from MSCs and facilitates the expansion of hematopoietic stem cells;Biotechnology and Bioengineering;2022-07-18

2. Sequential Transplantation of Haploidentical Stem Cell and Unrelated Cord Blood With Using ATG/PTCY Increases Survival of Relapsed/Refractory Hematologic Malignancies;Frontiers in Immunology;2021-11-04

3. Guidelines for Adult Patient Selection and Conditioning Regimens in Cord Blood Transplant Recipients with Hematologic Malignancies and Aplastic Anemia;Transplantation and Cellular Therapy;2021-04

4. Optimizing Donor Choice and GVHD Prophylaxis in Allogeneic Hematopoietic Cell Transplantation;Journal of Clinical Oncology;2021-02-10

5. CD4+ T-cell alloreactivity after haploidentical hematopoietic stem cell transplantation;Haematologica;2020-03-12